Patents by Inventor Hadas Tamar PAHIMA

Hadas Tamar PAHIMA has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • USE OF HEXOKINASE 2/MITOCHONDRIA-DETACHING COMPOUNDS FOR TREATING HEXOKINASE-2 (HK2)-EXPRESSING CANCERS
    Publication number: 20220143004
    Abstract: The present invention provides methods of use of hexokinase 2 (HK2)/mitochondria-detaching compounds, including jasmonate derivatives and piperazine derivatives and pharmaceutical compositions including such compounds for treating, inhibiting, or suppressing a hexokinase-2 (HK2)-expressing cancer.
    Type: Application
    Filed: January 25, 2022
    Publication date: May 12, 2022
    Applicant: Vidac Pharma Ltd.
    Inventors: Vered BEHAR, Oren Menahem BECKER, Hadas Tamar PAHIMA, Reut YOSEF HAMO
  • Use of hexokinase 2/mitochondria-detaching compounds for treating hexokinase-2 (HK2)-expressing cancers
    Patent number: 11266639
    Abstract: The present invention provides methods of use of hexokinase 2 (HK2)/mitochondria-detaching compounds, including jasmonate derivatives and piperazine derivatives and pharmaceutical compositions including such compounds for treating, inhibiting, or suppressing a hexokinase-2 (HK2)-expressing cancer.
    Type: Grant
    Filed: November 7, 2017
    Date of Patent: March 8, 2022
    Assignee: VIDAC PHARMA LTD.
    Inventors: Vered Behar, Oren Menahem Becker, Hadas Tamar Pahima, Reut Yosef Hamo
  • USE OF HEXOKINASE 2/MITOCHONDRIA-DETACHING COMPOUNDS FOR TREATING HEXOKINASE-2 (HK2)-EXPRESSING CANCERS
    Publication number: 20180303820
    Abstract: The present invention provides methods of use of hexokinase 2 (HK2)/mitochondria-detaching compounds, including jasmonate derivatives and piperazine derivatives and pharmaceutical compositions including such compounds for treating, inhibiting, or suppressing a hexokinase-2 (HK2)-expressing cancer.
    Type: Application
    Filed: November 7, 2017
    Publication date: October 25, 2018
    Applicant: Vidac Pharma Ltd.
    Inventors: Vered BEHAR, Oren Menahem BECKER, Hadas Tamar PAHIMA, Reut YOSEF HAMO